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Summary
Serine and threonine residues inmany proteins can be
modified by either phosphorylation or GlcNAcylation.
To investigate the mechanism of O-GlcNAc and
O-phosphate’s reciprocal roles in modulating the
degradation and activity of murine estrogen receptor
b (mER-b), the conformational changes induced by
O-GlcNAcylation and O-phosphorylation of Ser16 in
17-mer model peptides corresponding to the N-termi-
nal intrinsically disordered (ID) region of mER-b were
studied by NMR techniques, circular dichroism (CD),
and molecular dynamics simulations. Our results
suggest that O-phosphorylation discourages the turn
formation in the S15STG18 fragment. In contrast,
O-GlcNAcylation promotes turn formation in this
region. Thus, we postulate that the different changes
of the local structure in the N-terminal S15STG18 frag-
ment of mER-b caused by O-phosphate or O-GlcNAc
modification might lead to the disturbances to the
dynamic ensembles of the ID region of mER-b, which
is related to its modulatory activity.
Introduction
Many proteins are posttranslationally modified, and the
resulting modifications are often essential for the proper
function of the proteins. Among the modifications, phos-
phorylation and 2-amino-2-deoxyglucosylation (GlcNA-
cylation) are unique in that they can both reversibly
occur on the same Ser or Thr residues [1–4]. Therefore,
it has been suggested that O-phosphorylation and
O-GlcNAcylation play reciprocal roles in regulating the
protein function. This reciprocal relation has been
proved on several well-studied proteins, such as RNA
Pol II, SV-40 large T-antigen, the c-Myc protooncogene
product, and estrogen receptor b (ER-b) [1, 3, 4]. How-
ever, it is still unclear at the molecular level that how
phosphorylation and GlcNAcylation can induce differ-
ences in structural and functional behavior.
*Correspondence: liym@mail.tsinghua.edu.cnIt has been shown that the O-phosphate moiety might
exert both direct and indirect effects on the protein con-
formation leading to the changes of steric characteristic,
affecting charge, and influencing the ability to form hy-
drogen bonds etc [5, 6]. For the O-GlcNAc modification,
it was suggested that the sugar residue might transiently
block phosphorylation site [3], or directly be involved in
receptor binding interaction. Alternatively, it might alter
the conformation of the peptide backbone [7, 8]. Wong
and coworkers have concluded that O-linked GlcNAcyl-
ation serves to promote turn-like structures by studying
the model peptides from the repeating C-terminal do-
main of RNA polymerase II [8] and mucosal addressin
cell adhesion molecule-1 (MadCAM-1) [7]. In addition,
recently Liang and coworkers have used a de novo de-
signed a-helical hairpin model peptide to address the
different effects of GlcNAcylation and phosphorylation
on its conformational properties [9]. Here, we have ex-
plored the molecular mechanism of phosphorylation
and GlcNAcylation’s reciprocal roles in the regulation
of protein function with peptides derived from the
proteins alternatively modified with O-phosphate or
O-GlcNAc moiety.
ER-b, homologous to estrogen receptor a, was dis-
covered as a new member of the steroid hormone re-
ceptor family in 1996 [10, 11]. The estrogen receptors
are the central components of the estrogen regulation
and belong to the nuclear receptor (NR) gene family of
transcription factors. Abnormalities in ER structure itself
or ER signal transduction pathways contribute to ER-
related genetic disorders such as osteoporosis, cardio-
vascular disease, diabetes, and cancer [11]. ER-b has
a high homology to ER-a in the DNA and ligand binding
domains but encodes a distinct N-terminal modulatory
domain containing activation function 1 region (AF1)
[12, 13]. Moreover, it was reported that the N-terminal
region of ER-b possesses the same intrinsically un-
structured characteristics in solution as the N-terminal
transactivity region of many other NRs [12]. Since it car-
ries out important biological functions and structural
plasticity, the N-terminal region of ER-b can be postu-
lated as an intrinsically disordered (ID) region, which
lacks rigid 3D structure, existing instead as the dynamic
ensembles of interconverting structures. ID proteins
represent a distinct protein tribe, with disorder being
an important structural element that exists at various
levels, i.e., with various equilibrium constants for the
order-to-disorder transition of the various ID proteins
and regions [14]. Because of their structural characteris-
tics, the widespread ID proteins are commonly involved
in recognition, regulation, and cell-signaling functions
[14, 15].
Hart and coworkers mapped the major O-GlcNAc site
on Ser16 near the N terminus of murine ER-b (mER-b),
which alternatively can be modified by O-phosphoryla-
tion [10, 16]. Furthermore, pulse-chase studies and lucif-
erase reporter assays showed that the reciprocal occu-
pancy of Ser16 by either an O-phosphate group or
O-GlcNAc moiety modulates the degradation and activ-
ity of mER-b. It was suggested that O-phosphorylation
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nectivities with Their Magnitudes
(A–C) OH-peptide 1 (A), OP-peptide 2 (B),
and OG-peptide 3 (C). The measures were
performed in aqueous solution at pH 3.5
and 278 K. Asterisks denote NOE connectiv-
ities of which the magnitudes could not be
determined due to resonance overlap.of Ser16 accelerates degradation of mER-b, whereas
O-GlcNAcylation was predicted to result in stabilization
[10]. In order to explore how phosphorylation and
GlcNacylation can cause different effects on mER-b,
we have prepared three peptide derivatives based on
the N-terminal Ala7-Gly23 sequence of mER-b: the
parent peptide Ac-A7VMNYSVPSSTGNLEGG23-NH2
(OH-peptide 1), the phosphopeptideAc-A7VMNYSVPSp
STGNLEGG23-NH2 (OP-peptide 2), and the GlcNAcy-
lated peptide Ac-A7VMNYSVPSgSTGNLEGG23-NH2
(OG-peptide 3). The structures of the three peptides
were studied in detail by NMR, circular dichroism (CD),
and molecular dynamics simulations (MD). These
studies show that the S15STG18 fragment of the OH-pep-
tide 1 containing the unmodified Ser16 residue adopts
a type II b-turn-like structure in equilibrium with random
conformers. In contrast, the OP-peptide 2 adopts a more
extended structure in the same region. The OG-peptide
3 adopts a type II b-turn-like conformation, and the
degree of turn formation for this peptide is higher than
that for the other two peptides. In addition, detailed
NOE data, chemical shift perturbation data, and molec-
ular dynamics simulation studies reveal the subtle dif-
ferences in the turn structures of the three peptides.
These results offer a plausible explanation of the differ-
ent effects of O-phosphorylation and O-GlcNAcylation
on mER-b.
Results and Discussion
NMR Resonance Assignments
Resonance assignments for the three peptides were
performed with TOCSY and NOESY data by using the
sequential assignment strategy, in which NMR reso-
nances were first classified according to their amino
acid spin systems in the TOCSY spectra and then unam-
biguously identified from sequential connectivities in the
NOESY spectra [28]. The sequential assignments and
chemical shifts of these three peptides are shown in
the Supplemental Data (available with this article online).
The resonances of the sugar residue in OG-peptide 3
were assigned primarily based on TOCSY spectra. The
amide proton of GlcNAc yielded strong TOCSY cross-
peaks to two signals at 3.72 and 3.53 ppm, which were
assigned to H2 and H3. Their shifts are close to the liter-
ature values for the model oligosaccharides (mean
values 3.56 and 3.40 ppm) [8], and the TOCSY intensities
are consistent with the expected large couplings of NH
to H2 and H2 to H3. The anomeric proton of GlcNAc
was well resolved at 4.59 ppm and exhibited crosspeaks
to the tentatively assigned H2 and H3 resonances in the
high-field quadrant of the TOCSY spectrum. The remain-
ing GlcNAc protons were assigned by analogy with
model compounds [8].Phosphorylation and GlcNAcylation of Ser16 Do Not
Change the cis/trans Equilibria of the Prolyl Peptide
Bonds in the Model Peptides
All of these three peptides have the potential to exist as
two separate conformers due to the cis/trans isomeriza-
tion around their Val13-Pro14 prolyl peptide bonds. Prolyl
cis/trans isomerization is a slow process with relaxation
times of the order of ten seconds in unstructured pep-
tides. Thus, isomerization is the rate-limiting step in
many biological processes, such as protein folding
and isomerspecific binding [29]. It has been reported
that phosphorylation resulted in minor increases or de-
creases in the amount of cis population [30]. Wong’s
group has founded that the O-GlcNAc moiety did not af-
fect the cis-trans-proline equilibrium, while the O-SLex
group was able to shift the equilibrium [7]. For the model
peptides from N-terminal of mER-b, the observation of
only one clear set of resonances in the NMR spectra
for each peptide and the strong dad(Val
13, Pro14) NOEs
(Supplemental Data) suggest that the prolyl peptide
bond for each peptide is predominantly in the trans
conformation. It could also be concluded that phos-
phorylation and GlcNAcylation of Ser16 do not change
the cis/trans equilibria of the prolyl peptide bonds in
the model peptides.
NOE Data Suggest that Phosphorylation
and GlcNAcylation Induce Different Structural
Changes to the mER-b N-Terminal Peptide
Short- and medium-range inter- and intraresidues NOEs
(Supplemental Data) between NH and aH (daN) and
between NH and NH (dNN) protons define the second
structure adopted by the peptides in aqueous solution.
The magnitudes of the important NOE connectivities
observed in these spectra are shown schematically in
Figure 1.
Strong daN(i,i+1) NOEs, which were generally ob-
served in extended structures [31, 32], occur along
most of the sequences of the three peptides. However,
dNN(i,i+1) or daN(i,i+2) NOE connectivities, which are in-
dications of helical or turn elements of structure, were
only observed in the region of S15STG18 containing the
phosphorylation/GlcNAcylation site of Ser16.
Two consecutive NH-NH NOEs were detected for
Ser16-Thr17 and Thr17-Gly18 in OH-peptide 1, while all
other sequential NH-NH NOEs were too weak to be
observed. In addition, significant crosspeaks at
daN(Ser
16,Thr17) and daN(Thr
17,Gly18) were detected.
Therefore, according to the NOEs description of turn
structures, we propose that the fragment S15STG18
adopts a turn-like structure [28, 33]. The most commonly
observed reverse turns in peptide and protein structure
are the four-residue b-turns. The NOEs diagnostic of
b-turns include daN(2,3), daN(3,4), daN(2,4), dNN(2,3),
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from Random Coil for OH-Peptide 1,
OP-Peptide 2, and OG-Peptide 3
Data were recorded at pH 3.5 and 278 K.and dNN(3,4) crosspeaks in which the numbering indi-
cates the position in the turn [28]. Since the crosspeak
at daN(Ser
16,Gly18) is absent (Figure 1), we attribute the
turn structure in S15STG18 to a b-turn-like conformer in
equilibrium with random conformers. This conclusion
is also consistent with the studies [12] that the N termi-
nus of mER-b is an intrinsically disordered (ID) region,
which lacks rigid 3D structure and exists instead as dy-
namic ensembles of interconverting structures. It was
reported that type I and type II b-turns might be distin-
guished by the relative strengths of the daN(2,3) and
dNN(2,3) crosspeaks. Type I b-turn displays a medium
daN(2,3) crosspeak and a strong dNN(2,3) crosspeak,
whereas type II b-turn displays the opposite trend
with a strong daN(2,3) crosspeak and a weak dNN(2,3)
crosspeak [28]. However, since the coexistence of
turn structure with random conformers which present
strong daN(i,i+1) NOEs, we can not attribute the b-turn
in OH-peptide 1 to one specific subtype according
to the relative strengths of the daN(2,3) and dNN(2,3)
crosspeaks.
OP-peptide 2 and OG-peptide 3 gave different NOE
signals compared with OH-peptide 1, indicating that
the local conformation in S15STG18 region is changed
upon O-phosphorylation or O-GlcNAcylation of Ser16.
For OP-peptide 2, the cross peak at dNN(Thr
17,Gly18) dis-
appears (Figure 1), while crosspeaks atdNN(pSer
16,Thr17),
daN(pSer
16,Thr17), and daN(Thr
17,Gly18) are still clear in the
NOE spectrum. The existence of dNN(Thr
17,Gly18) could
indicate that there still exist a certain amount of turn-
like conformers in S15STG18 region after the phosphory-
lation of Ser16. However, the structure might have been
changed away from a b-turn, and the degree of this
turn structure might also have been changed. Thus, we
propose that the O-phosphate moiety causes the local
conformation near the Ser16 residue in mER-b to be
more extended.
Analysis of the NOE spectrum of OG-peptide 3 reveals
that upon O-GlcNAcylation of Ser16, a new crosspeak
at daN(gSer
16,Gly18) was observed in addition to cross-
peaks at daN(gSer
16,Thr17), dNN(gSer
16, Thr17),daN(Thr
17,Gly18), and dNN(Thr
17,Gly18), indicating
a more organized turn structure in the S15gSTG18 frag-
ment. Considering cross peaks at daN(gSer
16,Thr17),
daN(Thr
17,Gly18), daN(gSer
16,Gly18), dNN(gSer
16, Thr17),
and dNN(Thr
17,Gly18), we propose the presence of
b-turn-like conformers adopted by S15gSTG18 of
OG-peptide 3 according to the NOEs diagnostic criteria
of b-turns [28]. Although O-GlcNAcylation of Ser16 do
not clearly change the structure away from the b-turn,
the presence of a cross peak at daN(gSer
16,Gly18)
strongly suggests that O-GlcNAc induces the changes
of local structure in the peptide backbone and appar-
ently stabilizes the turn structure in S15gSTG18 region.
In addition, the crosspeak at db1(gSer
16,GlcNAc) was
observed in the NOE spectrum of OG-peptide 3, indicat-
ing that the H1 of the GlcNAc residue maintains a weak
interaction with the bH of gSer16. Other researchers have
founded that the 2-N-acetamido group in GlcNAc ex-
erted effects on the glycopeptide’s conformation [34].
However, no NOESY crosspeaks between 2-amide pro-
ton in GlcNAc and protons of backbone were observed
in OG-peptide 3.
Chemical Shift Perturbations Corroborate
the Changes of the Local Structure Caused
by Phosphorylation and GlcNAcylation of Ser16
It is established that differences in aH chemical shifts
from random coil values provide an indication of the
presence of a secondary structure [35, 36]. The aH
chemical shifts of OH-peptide 1 and its phosphory-
lated/glycosylated derivatives OP-peptide 2 and OG-
peptide 3 were compared to each other as well as to
random coil aH chemical shifts (Figure 2). While there
are small deviations (<0.1 ppm) from random coil aH
chemical shifts for most residues in each peptide,
the aH chemical shift for Ser16 in OP-peptide 2 or OG-
peptide 3 is markedly different from that of Ser16 in
OH-peptide 1. It is likely that there still exist populations
of extended conformers for all of these peptides, but
local structures are changed due to phosphorylation
and GlcNAcylation.
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the effects of the O-phosphate and O-GlcNAc moieties
on the secondary structure of our target peptide derived
from mER-b, changes of the backbone NH chemical
shifts upon phosphorylation (dOP-peptide 2-dOH-peptide 1)
and GlcNAcylation (dOG-peptide 3-dOH-peptide 1) were calcu-
lated for each residue (summarized in Figure 3). The NH
chemical shifts can provide insights into substitution ef-
fects and are particularly sensitive to hydrogen-bonding
interactions [37]. Perturbations to NH chemical shifts are
indicators of secondary structure formation and can
provide a method of estimating the population of folded
structures [35, 36]. Therefore, differences of NH chemi-
cal shifts between OP-peptide 2 and OH-peptide 1 and
between OG-peptide 3 and OH-peptide 1 are expected
to reflect perturbations due to the secondary structure
formation. The NH of pSer16 in OP-peptide 2 undergoes
a significant downfield shift, while there is a small upfield
shift for the corresponding gSer16 in OG-peptide 3. As
was mentioned above [29], this significant downfield
shift may reflect both intrinsic effects and the formation
of a hydrogen bond between the amide proton of pSer16
and phosphate group of pSer16. The hydrogen bond be-
tween the phosphate and amide group in a phosphopep-
tide has been proposed as a low-barrier hydrogen bond
by Du et al. from our group and is suggested to play
a role in the control of enzyme activities [38]. The upfield
shift of gSer16 NH in OG-peptide 3 may be explained by
the anisotropic effect of the carbonyl group of Ser15,
which is forced into close proximity in the folded turn
conformation [39]. Moreover, the amide protons of
Thr17 and Gly18 in OG-peptide 3 shift significantly to
upfield, too. It was reported that the magnitude of the
NH chemical shift deviations of the corresponding resi-
dues can provide a good estimate for the degree of
Figure 3. NH Chemical Shifts Differences from Those of OH-Pep-
tide 1 for OP-Peptide 2 and OG-Peptide 3
Data were recorded at pH 3.5 and 278 K. Positive values are down-
field shifts, and negative values are upfield shifts.turn formation [40]. Thus, we propose that GlcNAcyla-
tion induces a more organized turn structure in the re-
gion of S15gSTG18.
Coupling Constants Are Likely the Ensemble
Average of Turn Structures with Other Extended
Conformers
Assuming a b-turn that is stably folded (100% popu-
lated) in solution, the local conformation is consistent
with a coupling constant of 4 Hz% 3JNa% 5 Hz. Inverse
g-turn structures are consistent with a coupling con-
stant of 6 Hz% 3JNa% 8 Hz [41]. As unstructured regions
of polypeptides also display 3JNa values within this
range, inverse g-turn conformations cannot be distin-
guished from ‘‘random coil’’ on the basis of coupling
constants alone. 3JNa coupling constants were mea-
sured through 1D 1H NMR and DQF-COSY spectrum
for all residues except Pro14 in the three model peptides
(Supplemental Data). All the 3JNa coupling constants fall
into 6.0–8.0 Hz range where structural predictions are
difficult to make. The coupling constants for residues
near the Ser16 residue in each peptide are likely the en-
semble average of turn structures with other extended
conformers. This inference is consistent with the NOE
data, which also suggests that there exist turn con-
formers in the S15STG18 region of each peptide in equi-
librium with random conformers of different degree.
VT Coefficient Studies Confirm the Existence
of Organized Structures around the Ser16 Residue
for Each Model Peptide
Variable temperature (VT) coefficient is a measure of
changes in the conformational equilibrium of partially
folded peptides as the system is heated and the peptide
goes from the folded to the random coil state [42].
Amide proton VT coefficient can provide information
on whether an exchangeable proton is protected from
solvent exchange due to hydrogen bond [43]. The VT
studies (Table 1) indicate that the VT coefficients of
Thr17 and Gly18 in each peptide are lower than those re-
corded for most other amide protons. Based on ‘‘solvent
shielding’’ theory, these lower VTs are consistent with
the existence of a local organized structure near the
Ser16 residue in each peptide as an increase in folded
structure would be expected to lead to an increase in
the protection of the backbone NH protons from solvent
exchange. Based on ‘‘equilibrium between states’’
[42], the lower VTs are consistent with shifts in the con-
formational equilibrium of the underlying peptide back-
bone. However, the small difference in VT coefficients
(<1.0 ppb/K) for the residues around Ser16 in OH-peptide
1, OP-peptide 2, and OG-peptide 3 cannot distinguish
the subtle changes in the local structures due to phos-
phorylation and GlcNAcylation. In addition, we found
that the amide proton VT coefficient of Ser12 in eachTable 1. VT Coefficients of Amide Protons in OH-Peptide 1, OP-Peptide 2, and OG-Peptide 3
VT A7 V M N Y S V P S S T G N L E G G23
1 6.7 8.2 7.8 6.8 8.0 4.1 7.5 8.2 7.8 5.4 4.9 5.0 6.8 5.1 5.7 5.4
2 6.2 8.2 7.8 6.8 8.0 4.1 7.5 7.9 7.2 5.2 3.9 4.7 6.8 6.1 6.3 4.6
3 6.9 8.5 7.7 7.2 8.4 4.5 7.7 8.9 6.9 4.9 5.1 5.1 7.1 6.5 6.8 5.5
VT coefficients were measured between 278 and 298 K (2Dppb/DK).
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concluded whether the amide proton of Ser12 in each
peptide is involved in hydrogen bond or defined struc-
ture formation.
CD Studies Corroborate the Existence of Some
Ordered Structures for Each Model Peptide and the
Different Perturbations to the Peptide Backbone
Caused by Phosphorylation and GlcNAcylation
To further study the conformation of the three model
peptides, CD spectra were obtained in the region of
186–260 nm in aqueous solution (Figure 4). The spec-
trum for each peptide is characterized by a negative
band around 198 nm attributed to disordered conforma-
tion and a negative shoulder around 220 nm indicative of
the existence of some folded conformations [8, 44].
Thus, it is suggested that OH-peptide 1, OP-peptide 2,
and OG-peptide 3 adopt defined conformers in equilib-
rium with random conformers. There are only small
differences around 220 nm for the three peptides. How-
ever, phosphorylation of Ser16 shifts its negative mini-
mum around 198 nm to slightly lower wavelength, which
might be caused by the structure perturbation, while
GlcNAcylation decreases the intensities of negative
band at 195–200 nm considerably, indicating the de-
crease of the disordered structures [44].
Molecular Dynamics Simulations Reflect
the Different Local Structures in the S15STG18
Region of Each Peptide
We have observed by NMR and CD that both phosphate
and GlcNAc groups could influence the conformation
and dynamics of the underlying peptide backbone.
Molecular dynamic simulations can provide a comple-
ment method to experimental techniques used for prob-
ing the conformational space populated by OH-peptide
1, OP-peptide 2, and OG-peptide 3. Moreover, they may
offer insight into the subtle differences of the turn-like
structures separately adopted by these three peptides,
within the limits of the used force-field and simulation
timescale, at an atomic level. Molecular dynamic simula-
tions were performed on a SGI workstation with Macro-
model v7.0 [27]. To reduce the computational time,
the truncated models of the three model peptides,
Figure 4. CD Spectra of the Three Model Peptides
The CD spectra were recorded at pH 3.5 and 298 K.Ac-Ser15-Ser-Thr-Gly-Asn19-NH2, Ac-Ser
15-Ser(-O-PO
(OH) (O2))-Thr-Gly-Asn19-NH2 (due to pH 3.5, the phos-
phate carries one negative charge), and Ac-Ser15-
Ser(-O-GlcNAc)-Thr-Gly-Asn19-NH2, were examined.
The NOE distances (Supplemental Data) generated
through the integration of crosspeaks from the NOESY
spectra of the three truncated peptides were applied
during molecular dynamics. In addition, the hydrogen
bond between the amide proton of pSer16 and phos-
phate group of pSer16 was interpreted to the distance
and angle constrains in molecular dynamics simulations
of OP-peptide 2. The amide bonds of peptide backbone
were constrained in the trans orientation. Thirty lowest
energy structures of the 100 final structures obtained
from the restrained MD simulations of each truncated
peptide were in superimposition (Supplemental Data).
Representative structure of each of three truncated pep-
tides is shown in Figure 5.
Consistent with the NMR measurements, molecular
dynamics simulations reveal that all three truncated
peptides exist in turn-like structures. For OH-peptide 1
and OG-peptide 3, the estimation through NMR data
that there exist b-turn-like conformers with different
degree and subtle structure in the S15STG18 region has
been confirmed by the computational modeling. It
was reported that b-turns could be subdivided into a
number of types based on the backbone angles 4 and
c of the residues in the loop [39]. Herein, the 4-angles
and c-angles for i+1 and i+2 residues (i = Ser15) in repre-
sentative structures of all three truncated peptides
were separately measured (summarized in Table 2).
Based on the subcategorization standards of b-turn
[45], truncated OH-peptide 1 was sorted into type II
b-turn category, except that 4-angle for i+1 has a small
deviation from the expected range. This observed non-
ideal type II b-turn in truncated OH-peptide 1 could be
caused by its engagement in equilibrium with random
conformers.
Truncated OG-peptide 3 was also sorted into type II
b-turn category, except that 4-angle for i+1 residue
has also a small deviation from the expected range,
too. It was reported that the attached carbohydrate
could influence the conformation and dynamics of the
underlying peptide backbone in two different ways: non-
specific steric effects or a specific peptide-sugar hydro-
gen bond [46]. In this case, nonspecific steric effects
promote the O-GlcNAc group to be away from the plate
of turn structure in S15STG18, resulting in a more stable
type II b-turn like structure. On the other hand, although
there was no clear hydrogen bond observed between
the peptide and the sugar moiety, interactions between
the peptide backbone and the sugar moiety were ob-
served in the NOEs, which were converted to distance
constrains and applied in molecular dynamics simula-
tions. The structure representation of truncated OG-
peptide 3 from constrained MD simulations supports
the conclusion from NOEs data that O-GlcNAcylation
stabilizes a b-turn structure around the site of Ser16.
Therefore, the O-GlcNAc group shifts the conforma-
tional equilibrium to the more stable b-turn, which is
consistent with the notion that glycosylation serves to
promote b-turn formation [7, 8, 47, 48].
According to the4-angles andc-angles for i+1 and i+2
residues in truncated OP-peptide 2, we are unable to
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Restrained MD Simulations of the Three
Truncated Peptides
(A) Truncated OH-peptide 1.
(B) Truncated OP-peptide 2.
(C) Truncated OG-peptide 3.sort it to any subtypes of turns. However, from the sim-
ulations results, it is inferred that there exists a turn-like
structure around pSer16, although the turn is compara-
tively less organized than those in truncated OH-peptide
1 and OG-peptide 3. The representative structure for
OP-peptide 2 (Figure 5) shows the existence of a hydro-
gen bond between the amide proton of pSer16 and the
phosphate group of pSer16 (the distance of hydrogen
bond N-H---O=P is 1.99 A˚, and the N-H---O angle is
138). It is likely that this hydrogen bond affects the dihe-
dral angles of OP-peptide 2, which leads to a destabiliza-
tion of the b-turn-like structure.
Altogether, the NMR data and the molecular dynamics
simulations results suggest that the O-phosphate moi-
ety and O-GlcNAc residue induce subtle disturbances
to the local structure of the N-terminal fragment of
mER-b. O-phosphorylation discourages the turn forma-
tion, and the phosphorylated peptide adopts a more
extended structure. In contrast, O-GlcNAcylation
promotes turn formation, and the O-GlcNAc-modified
peptide adopts a more stable structure. These results
are consistent with the functional observation that
O-phosphorylation of mER-b promotes its degradation,
while O-GlcNAcylation stabilizes the protein [10].
Perhaps O-phosphorylation causes mER-b to be more
accessible to proteinases due to the lack of stable
structure in the N-terminal region, while O-GlcNAcyla-
tion increases the stability of mER-b to proteolytic deg-
radation because of secondary structure formation.
Therefore, we postulate the possibility that conforma-
tional changes induced by alternative O-phosphate
and O-GlcNAc modification of Ser16 might be related
Table 2. The 4-Angles and c-Angles in Representative Structures
of All Three Truncated Peptides
Truncated Peptide Fi+1 Ji+1 Fi+2 Ji+2
1(rep) 2148.1 121.8 60.9 14.6
2(rep) 40.1 46.5 2144.1 127.6
3(rep) 2154.0 156.7 56.6 16.8
i represents Ser15 residue.to their reciprocal roles in modulating the bioactivity of
mER-b.
Significance
The reciprocal modification of Ser16 by either O-phos-
phate or O-GlcNAc modulates the degradation and
activity of mER-b. Here, we have explored the confor-
mation adjusting effects of two modifications on the
N-terminal intrinsically disordered (ID) region of
mER-b (an activity modulatory domain) with 17-mer
model peptides. The NMR, CD, and molecular dynam-
ics simulations results show that OH-peptide 1,
OP-peptide 2, and OG-peptide 3 adopt different types
of turn-like structures with distinct degree in equilib-
rium with random conformers of the S15STG18 frag-
ments. OH-peptide 1 prefers to adopt a certain popula-
tion of type II b-turn-like structure. In contrast,
OP-peptide 2 adopts a more extended structure in
the same region, which was hypothesized to be
caused by the hydrogen bond between the amide pro-
ton of pSer16 and the phosphate group of pSer16.
Although the SgS16TG fragment of OG-peptide 3 also
assumes a type II b-turn-like conformation, the
O-GlcNAc group induces a change of dihedral angles
around the site of Ser16 leading to a higher degree of
type II b-turn-like structure in this region. These re-
sults are consistent with the functional observations
that O-phosphorylation promotes degradation of
mER-b, while O-GlcNAcylation increases the stability
of mER-b toward proteinases. Extrapolating these re-
sults to the full-length protein, it is likely that the
changes of the local structure in the N-terminal frag-
ment S15STG18 of mER-b induced by O-phosphoryla-
tion and O-GlcNAcylation lead to the disturbance to
the dynamic ensembles of the ID region of mER-b
and may explain the different roles of O-phosphoryla-
tion andO-GlcNAcylation inmodulating the bioactivity
of mER-b. It is interesting to investigate whether
similar conclusions can be drawn for other proteins
that are reciprocally regulated by O-phosphorylation
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943and O-GlcNAcylation, such as RNA Pol II, SV-40 large
T-antigen, and the c-Myc protooncogene product.
Experimental Procedures
Synthesis
The three peptides were synthesized on Rink Amide AM resin by
using standard Fmoc chemistry and O-benzotriazol-N,N,N0,N0-
tetramethyluronium hexafluorophosphate/1-hydroxybenzotriazol
(HBTU/HOBt) coupling protocol [17]. The amino acids were com-
mercially available except for Fmoc-Ser(Ac3-b-O-GlcNAc)-OH,
which was prepared by a literature procedure [8]. The peptides
and all protecting groups except the O-acetyl groups on the N-acetyl
glucosamine were cleaved from the resin with TFA containing phe-
nol (5%), thioanisole (5%), ethanedithiol (2.5%), and water (5%) for
120 min [18]. The crude peptides were purified by reverse-phase
HPLC by using an ODS-UG-5 column (Develosil) with a linear gradi-
ent of 20%–50% acetonitrile containing 0.06% trifluoroacetic acid as
an ion-pairing reagent. Purified OG-peptide 3 with acetyl-protecting
GlcNAc(OAc)3 was deprotected by 0.1M NaOMe in methanol and
finally purified by SepPak-C18. The integrity of each peptide was
verified by ESI-MS.
NMR Spectroscopy
Each peptide sample for NMR measurements was dissolved in H2O/
D2O 9:1 (v/v) in 10 mM phosphate buffer. The pH value was adjusted
to 3.5 by adding HCl or NaOH. Sodium 2,2-dimethyl-2-silapento-
nate-d4 was used as an external standard. Standard NOESY and
TOCSY experiments were collected on a Varian Inova-600 spec-
trometer operating at a frequency of 599.83 MHz for 1H nucleus
[19, 20]. DQF-COSY experiments were recorded to determine
3JNH- aH coupling constants [21, 22]. Two-dimensional NMR data
were transferred to an Indigo 2 (Silicon Graphics, Inc.) computer
workstation and processed with the nmrPipe/nmrDraw program
[23]. Usually, a sine-squared window function shifted by p/4 to p/2
was applied in both dimensions, with zero filling in f1 to 2K points.
Quadrature detection in f1 was achieved with TPPI [24]. H2O reso-
nance was suppressed either by presaturation of the solvent peak
during the relaxation delay (and the mixing time in the NOESY spec-
tra) or by using a pulsed-field gradient techniques with a WATER-
GATE sequence [25, 26]. Generally, spectra were collected with
2 K points in f2 and 512 in f1.
Circular Dichroism
CD spectra were recorded on a Jasco 720 spectropolarimeter from
260 to 186 nm in a 0.1 cm path length cell at room temperature. Each
peptide sample was dissolved in 10 mM phosphate buffer at pH 3.5
and a concentration of about 0.2 mg/ml. Four scans were averaged.
All spectra were corrected by subtracting the baseline of the solvent
buffer solution recorded under the same conditions. The results
were expressed as mean residue ellipticity [q] in units of degrees
cm2 dmol21.
Molecular Dynamics Simulations
Interproton distance restraints for the three peptides were gener-
ated through integration of crosspeaks from NOESY spectra
acquired at 278 K. The integral volumes obtained were converted
to distance restraints with the following classifications: strong
(2.0 A˚ % rij % 3.0A˚), medium (2.0 A˚ % rij % 4.0 A˚), and weak
(2.0 A˚ % rij % 5.0 A˚). Distance-restrained MD simulations with the
GB/SA solvent and at the Amber force field were performed with
Macromodel v7.0 [27] on a SGI workstation. All amide bonds were
constrained in the trans orientation during the calculations. Energy
minimization using the conjugate gradient method, to a derivative
of less than 0.01 kal/A˚, was performed prior to each MD calculation.
This protocol consists of a total of 20 ps of molecular dynamics at
1000 K. Then, the system was cooled to 300 K over 200 ps of molec-
ular dynamics and equilibrated for 100 ps at 300 K to generate 100
structures. Thirty lowest energy structures for each peptide were se-
lected for further analysis. Statistical analysis, superimposition of
structures, 3D graphic displays, and manipulations were achieved
by using XCluster and Macromodel software.Supplemental Data
Supplemental text, tables, and figures describing NMR and MD sim-
ulations results of OH-peptide 1, OP-peptide 2, and OG-peptide 3,
the synthesis rout of Fmoc-Ser-(O-b-GlcNAc(OAc)3COOH), are
available online at http://www.chembiol.com/cgi/content/full/13/9/
937/DC1/.
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